Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Subacute delayed ascending myelopathy: not just a post-traumatic disorder.

Tan AC, Ng K, Newey A, Leong G.

Spinal Cord. 2014 Aug;52 Suppl 2:S11-3. doi: 10.1038/sc.2014.82.

PMID:
25082375
[PubMed - in process]
2.

The outcomes of primary pediatric keratoplasty in singapore.

Low JR, Anshu A, Tan AC, Htoon HM, Tan DT.

Am J Ophthalmol. 2014 Sep;158(3):496-502. doi: 10.1016/j.ajo.2014.05.020. Epub 2014 May 27.

PMID:
24875001
[PubMed - in process]
3.

Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.

Kim J, Vasu VT, Mishra R, Singleton KR, Yoo M, Leach SM, Farias-Hesson E, Mason RJ, Kang J, Ramamoorthy P, Kern JA, Heasley LE, Finigan JH, Tan AC.

Bioinformatics. 2014 Sep 1;30(17):2393-8. doi: 10.1093/bioinformatics/btu323. Epub 2014 May 7.

PMID:
24812339
[PubMed - in process]
4.

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Wynes MW, Hinz TK, Gao D, Martini M, Marek LA, Ware KE, Edwards MG, Böhm D, Perner S, Helfrich BA, Dziadziuszko R, Jassem J, Wojtylak S, Sejda A, Gozgit JM, Bunn PA Jr, Camidge DR, Tan AC, Hirsch FR, Heasley LE.

Clin Cancer Res. 2014 Jun 15;20(12):3299-309. doi: 10.1158/1078-0432.CCR-13-3060. Epub 2014 Apr 25.

PMID:
24771645
[PubMed - in process]
5.

[The Ogilvie syndrome in elderly patients with multimorbidity].

Tan AC, Olde Rikkert MG, Groenen MJ.

Tijdschr Gerontol Geriatr. 2014 Jun;45(3):164-9. doi: 10.1007/s12439-014-0071-7. Dutch.

PMID:
24764153
[PubMed - in process]
6.

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.

Morrison JA, Pike LA, Sams SB, Sharma V, Zhou Q, Severson JJ, Tan AC, Wood WM, Haugen BR.

Mol Cancer. 2014 Mar 19;13:62. doi: 10.1186/1476-4598-13-62.

PMID:
24645981
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.

Mifsud EJ, Tan AC, Jackson DC.

Front Immunol. 2014 Mar 3;5:79. doi: 10.3389/fimmu.2014.00079. eCollection 2014. Review.

PMID:
24624130
[PubMed]
Free PMC Article
8.

Candida glabrata vertebral osteomyelitis in an immunosuppressed patient.

Tan AC, Parker N, Arnold M.

Int J Rheum Dis. 2014 Feb;17(2):229-31. doi: 10.1111/1756-185X.12113. Epub 2013 Jun 19. No abstract available.

PMID:
24576284
[PubMed - in process]
9.

Challenges and solutions for a rational vaccine design for TB-endemic regions.

Gowthaman U, Mushtaq K, Tan AC, Rai PK, Jackson DC, Agrewala JN.

Crit Rev Microbiol. 2014 Feb 4. [Epub ahead of print]

PMID:
24495096
[PubMed - as supplied by publisher]
10.

Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies.

Bowles DW, Diamond JR, Lam ET, Weekes CD, Astling DP, Anderson RT, Leong S, Gore L, Varella-Garcia M, Vogler BW, Keysar SB, Freas E, Aisner DL, Ren C, Tan AC, Wilhelm F, Maniar M, Eckhardt SG, Messersmith WA, Jimeno A.

Clin Cancer Res. 2014 Mar 15;20(6):1656-65. doi: 10.1158/1078-0432.CCR-13-2506. Epub 2014 Feb 3.

PMID:
24493827
[PubMed - in process]
Free PMC Article
11.

Automatic context-specific subnetwork discovery from large interaction networks.

Saha A, Tan AC, Kang J.

PLoS One. 2014 Jan 1;9(1):e84227. doi: 10.1371/journal.pone.0084227. eCollection 2014.

PMID:
24392115
[PubMed - in process]
Free PMC Article
12.

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.

Davies KD, Mahale S, Astling DP, Aisner DL, Le AT, Hinz TK, Vaishnavi A, Bunn PA Jr, Heasley LE, Tan AC, Camidge DR, Varella-Garcia M, Doebele RC.

PLoS One. 2013 Dec 13;8(12):e82236. doi: 10.1371/journal.pone.0082236. eCollection 2013.

PMID:
24349229
[PubMed - in process]
Free PMC Article
13.

Ocular manifestations and the clinical course of carotid cavernous sinus fistulas in Asian patients.

Tan AC, Farooqui S, Li X, Tan YL, Cullen J, Lim W, Leng SL, Looi A, Tow S.

Orbit. 2014 Feb;33(1):45-51. doi: 10.3109/01676830.2013.851253. Epub 2013 Nov 6.

PMID:
24195725
[PubMed - indexed for MEDLINE]
14.

DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.

Khor GH, Froemming GR, Zain RB, Abraham MT, Omar E, Tan SK, Tan AC, Vincent-Chong VK, Thong KL.

Int J Med Sci. 2013 Oct 12;10(12):1727-39. doi: 10.7150/ijms.6884. eCollection 2013.

PMID:
24155659
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

BEReX: Biomedical Entity-Relationship eXplorer.

Jeon M, Lee S, Lee K, Tan AC, Kang J.

Bioinformatics. 2014 Jan 1;30(1):135-6. doi: 10.1093/bioinformatics/btt598. Epub 2013 Oct 21.

PMID:
24149052
[PubMed - indexed for MEDLINE]
16.

K-Map: connecting kinases with therapeutics for drug repurposing and development.

Kim J, Yoo M, Kang J, Tan AC.

Hum Genomics. 2013 Sep 23;7:20. doi: 10.1186/1479-7364-7-20.

PMID:
24060470
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

From bench to bedside: lessons learned in translating preclinical studies in cancer drug development.

Lieu CH, Tan AC, Leong S, Diamond JR, Eckhardt SG.

J Natl Cancer Inst. 2013 Oct 2;105(19):1441-56. doi: 10.1093/jnci/djt209. Epub 2013 Sep 19. Review.

PMID:
24052618
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Polymorphisms in alcohol-metabolizing enzymes and esophageal carcinoma susceptibility: a Dutch Caucasian case-control study.

Dura P, Berkers T, van Veen EM, Salomon J, te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

J Hum Genet. 2013 Nov;58(11):742-8. doi: 10.1038/jhg.2013.95. Epub 2013 Sep 19.

PMID:
24048263
[PubMed - indexed for MEDLINE]
19.

Overcoming IGF1R/IR resistance through inhibition of MEK signaling in colorectal cancer models.

Flanigan SA, Pitts TM, Newton TP, Kulikowski GN, Tan AC, McManus MC, Spreafico A, Kachaeva MI, Selby HM, Tentler JJ, Eckhardt SG, Leong S.

Clin Cancer Res. 2013 Nov 15;19(22):6219-29. doi: 10.1158/1078-0432.CCR-13-0145. Epub 2013 Sep 17.

PMID:
24045180
[PubMed - indexed for MEDLINE]
20.

The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.

Anderson RT, Keysar SB, Bowles DW, Glogowska MJ, Astling DP, Morton JJ, Le P, Umpierrez A, Eagles-Soukup J, Gan GN, Vogler BW, Sehrt D, Takimoto SM, Aisner DL, Wilhelm F, Frederick BA, Varella-Garcia M, Tan AC, Jimeno A.

Mol Cancer Ther. 2013 Oct;12(10):1994-2005. doi: 10.1158/1535-7163.MCT-13-0206. Epub 2013 Jul 19.

PMID:
23873848
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk